Cannabis use disorder market seen reaching $2.35 billion by 2030

The Business Research Company says the cannabis use disorder market will rise from $1.65 billion in 2025 to $1.78 billion in 2026, then reach $2.35 billion by 2030. Growth is tied to rising cannabis use, broader diagnosis, telehealth and digital mental health tools, and more combined treatment approaches.

Why it matters: - Cannabis use disorder is moving from a niche treatment category to a larger behavioral health market as more patients are identified and treated. - Rising demand could shape rehab services, telehealth programs, digital therapeutics and addiction research funding. - The market expansion reflects broader recognition of substance use disorders as a healthcare issue rather than a stigma-only issue.

What happened: - The Business Research Company released a 2026 report on the global cannabis use disorder market. - The report puts the market at $1.65 billion in 2025 and $1.78 billion in 2026. - The report forecasts the market will reach $2.35 billion by 2030. - North America held the largest market share in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The report is available as a full market report, and a free sample is also available.

The details: - The report says historical growth was driven by higher cannabis use, greater awareness of substance use disorders, more rehabilitation services, improved recognition of mental health challenges and wider use of behavioral therapy programs. - The forecast period is expected to be supported by broader acceptance of digital mental health platforms, higher funding for addiction research, growth in telehealth treatment, a stronger focus on outcome-driven care and integration of pharmacological and behavioral therapies. - The report highlights rising adoption of combined behavioral and pharmacological approaches. - The report also points to personalized addiction treatment plans, digital therapeutics, remote patient monitoring, multidisciplinary care models, and earlier diagnosis and intervention as key trends. - Cannabis use disorder is defined as problematic or excessive cannabis consumption that causes significant distress or impairment. - The condition falls under substance use disorders and can affect mental, physical and social well-being. - UK data from the Office for Health Improvement and Disparities showed the share of new patients seeking treatment for cannabis-related issues rose from 20.9% to 21.4% in November 2024. - The same UK data showed new benzodiazepine-related cases increased from 3,620 in 2022-2023 to 3,872.

Between the lines: - The market story is less about cannabis itself and more about the healthcare systems built around diagnosis, treatment and follow-up. - The shift toward digital care and remote monitoring suggests providers want scalable treatment models, not only in-person rehab. - The growing focus on early intervention and personalized plans signals a more clinical, outcomes-based approach to addiction care.

What's next: - The report expects continued growth through 2030 as telehealth, digital mental health tools and combined treatment models expand. - More regions may build out treatment infrastructure as awareness and diagnosis improve. - The report says newer 2026 editions include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables.

The bottom line: - Cannabis use disorder is becoming a larger, more data-driven treatment market, with growth tied to better diagnosis, broader care access and expanding digital health options.